NEW DELHI: Biotechnology agency Biocon on Thursday stated its consolidated revenue after tax rose over six-fold to Rs 660 crore within the first quarter ended June 2024, on account of a one-time achieve from the collaboration between Biocon Biologics and Eris Lifesciences.
